These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 12413521)

  • 1. From allergen structure to new forms of allergen-specific immunotherapy.
    Valenta R; Kraft D
    Curr Opin Immunol; 2002 Dec; 14(6):718-27. PubMed ID: 12413521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant Allergens in Structural Biology, Diagnosis, and Immunotherapy.
    Tscheppe A; Breiteneder H
    Int Arch Allergy Immunol; 2017; 172(4):187-202. PubMed ID: 28467993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergy diagnosis, allergen repertoires, and their implications for allergen-specific immunotherapy.
    Crameri R
    Immunol Allergy Clin North Am; 2006 May; 26(2):179-89, v. PubMed ID: 16701139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for converting allergens into hypoallergenic vaccine candidates.
    Vrtala S; Focke-Tejkl M; Swoboda I; Kraft D; Valenta R
    Methods; 2004 Mar; 32(3):313-20. PubMed ID: 14962766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity.
    Focke M; Swoboda I; Marth K; Valenta R
    Clin Exp Allergy; 2010 Mar; 40(3):385-97. PubMed ID: 20210812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future.
    Valenta R; Campana R; Focke-Tejkl M; Niederberger V
    J Allergy Clin Immunol; 2016 Feb; 137(2):351-7. PubMed ID: 26853127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant allergens: what does the future hold?
    Valenta R; Niespodziana K; Focke-Tejkl M; Marth K; Huber H; Neubauer A; Niederberger V
    J Allergy Clin Immunol; 2011 Apr; 127(4):860-4. PubMed ID: 21458656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant marker allergens: diagnostic gatekeepers for the treatment of allergy.
    Kazemi-Shirazi L; Niederberger V; Linhart B; Lidholm J; Kraft D; Valenta R
    Int Arch Allergy Immunol; 2002 Apr; 127(4):259-68. PubMed ID: 12021544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant proteins and peptides as diagnostic and therapeutic reagents for arthropod allergies.
    Ramos JD; Valmonte GR; de Guia RM
    Protein Pept Lett; 2007; 14(10):992-1002. PubMed ID: 18220997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From allergen genes to new forms of allergy diagnosis and treatment.
    Vrtala S
    Allergy; 2008 Mar; 63(3):299-309. PubMed ID: 18269675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The major cat allergen, Fel d 1, in diagnosis and therapy.
    Grönlund H; Saarne T; Gafvelin G; van Hage M
    Int Arch Allergy Immunol; 2010; 151(4):265-74. PubMed ID: 19844127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From allergen genes to allergy vaccines.
    Valenta R; Ferreira F; Focke-Tejkl M; Linhart B; Niederberger V; Swoboda I; Vrtala S
    Annu Rev Immunol; 2010; 28():211-41. PubMed ID: 20192803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotechnology-based allergy diagnosis and vaccination.
    Bhalla PL; Singh MB
    Trends Biotechnol; 2008 Mar; 26(3):153-61. PubMed ID: 18222557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic allergen modification in the development of novel approaches to specific immunotherapy.
    Mutschlechner S; Deifl S; Bohle B
    Clin Exp Allergy; 2009 Nov; 39(11):1635-42. PubMed ID: 19624521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergen immunotherapy: current and new therapeutic strategies.
    Rolland JM; Douglass J; O'Hehir RE
    Expert Opin Investig Drugs; 2000 Mar; 9(3):515-27. PubMed ID: 11060692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammalian-derived respiratory allergens - implications for diagnosis and therapy of individuals allergic to furry animals.
    Nilsson OB; van Hage M; Grönlund H
    Methods; 2014 Mar; 66(1):86-95. PubMed ID: 24041755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Aspects of Allergens and Allergy.
    Valenta R; Karaulov A; Niederberger V; Gattinger P; van Hage M; Flicker S; Linhart B; Campana R; Focke-Tejkl M; Curin M; Eckl-Dorna J; Lupinek C; Resch-Marat Y; Vrtala S; Mittermann I; Garib V; Khaitov M; Valent P; Pickl WF
    Adv Immunol; 2018; 138():195-256. PubMed ID: 29731005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant allergens for immunotherapy: state of the art.
    Zhernov Y; Curin M; Khaitov M; Karaulov A; Valenta R
    Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):402-414. PubMed ID: 31082821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant allergens.
    Valenta R; Vrtala S; Laffer S; Spitzauer S; Kraft D
    Allergy; 1998 Jun; 53(6):552-61. PubMed ID: 9689336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically engineered and synthetic allergen derivatives: candidates for vaccination against type I allergy.
    Valenta R; Vrtala S; Focke-Tejkl M; Bugajska-Schretter ; Ball T; Twardosz A; Spitzauer S; Grönlund H; Kraft D
    Biol Chem; 1999; 380(7-8):815-24. PubMed ID: 10494830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.